Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Ototoxicity × Chemoradiotherapy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Lung Neoplasms 3 Glioblastoma 2 Vaginal Neoplasms 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Radiation Injuries 1 Ototoxicity 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Lymphatic Metastasis 1 Locally Advanced Cervical Cancer 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Hearing Loss 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Cognitive Dysfunction 1 Cholangiocarcinoma 1 Cardiovascular Diseases 1 Cardiotoxicity 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Adult Patients With Locally Advanced Rectal Cancer Indicated to Neoadjuvant Therapy and Surgery 1

Interventions

Vincristine 1 Surveys and Questionnaires 1 Radiotherapy 1 Radiosurgery 1 Methotrexate 1 Mental Status and Dementia Tests 1 Magnetic Resonance Spectroscopy 1 Genetic Association Studies 1 Drug Therapy 1 Cyclophosphamide 1 Cisplatin 1 Chemotherapy, Adjuvant 1 Chemoradiotherapy 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06551857 2025-04-16

CaSPiN

Turku University Hospital

Ototoxicity, Neoplasms, Hearing Loss, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡